Increased Cell Wall Teichoic Acid Production and D-alanylation Are Common Phenotypes among Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates

Mechanisms of daptomycin resistance inStaphylococcus aureus: role of the cell membrane and cell wall

(2012) Arnold S. Bayer et al.   Annals of the New York Academy of Sciences

Nutrient-Dependent Structural Changes in S. aureus Peptidoglycan Revealed by Solid-State NMR Spectroscopy

(2012) Xiaoxue Zhou et al.   BIOCHEMISTRY

Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical Methicillin-Resistant Staphylococcus aureus Isolates Obtained before and after Daptomycin Treatment Failure

(2011) Susan Boyle-Vavra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New Role of the Disulfide Stress Effector YjbH in β-Lactam Susceptibility of Staphylococcus aureus

(2011) Nadine Göhring et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

(2011) Nagendra N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach

(2011) Adrien Fischer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids

(2011) Christoph M. Ernst et al.   MOLECULAR MICROBIOLOGY

Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms

(2010) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains

(2009) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus

(2009) N. N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureus

(2009) Soo‐Jin Yang et al.   JOURNAL OF INFECTIOUS DISEASES

Serial Daptomycin Selection Generates Daptomycin-Nonsusceptible Staphylococcus aureus Strains with a Heterogeneous Vancomycin-Intermediate Phenotype

(2008) I. L. B. d. C. Camargo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Toward the Pathway of S. aureus WTA Biosynthesis

(2008) Guoqing Xia et al.   CHEMISTRY & BIOLOGY

A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway

(2008) Sarah Dubrac et al.   MOLECULAR MICROBIOLOGY